Volume | 366,077 |
|
|||||
News | (1) | ||||||
Day High | 141.01 | Low High |
|||||
Day Low | 139.03 |
Share Name | Share Symbol | Market | Stock Type |
---|---|---|---|
Quest Diagnostics Inc | DGX | NYSE | Common Stock |
Open Price | Low Price | High Price | Close Price | Previous Close |
---|---|---|---|---|
139.41 | 139.03 | 141.01 | 139.16 |
Trades | Shares Traded | VWAP | Financial Volume | Average Volume | 52 Week Range |
---|---|---|---|---|---|
10,178 | 366,077 | US$ 140.45 | US$ 51,414,534 | - | 119.59 - 145.58 |
Last Trade | Type | Quantity | Price | Currency |
---|---|---|---|---|
13:24:35 | 1 | US$ 140.63 | USD |
Quest Diagnostics Inc Financials
Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
---|---|---|---|---|---|---|
15.6B | 110.71M | - | 9.25B | 854M | 7.71 | 18.26 |
Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
---|---|---|---|---|---|
- | - | - | - |
Quest Diagnostics News
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical DGX Price Data
Period † | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
---|---|---|---|---|---|---|---|
1 Week | 137.22 | 141.73 | 136.00 | 138.87 | 725,469 | 3.44 | 2.51% |
1 Month | 127.62 | 142.46 | 125.42 | 135.46 | 1,057,406 | 13.05 | 10.22% |
3 Months | 124.06 | 142.46 | 123.30 | 131.26 | 966,082 | 16.61 | 13.38% |
6 Months | 133.73 | 143.6299 | 123.04 | 132.19 | 997,849 | 6.94 | 5.19% |
1 Year | 129.82 | 145.58 | 119.59 | 132.18 | 933,990 | 10.85 | 8.35% |
3 Years | 135.81 | 174.16 | 119.59 | 138.60 | 1,057,019 | 4.85 | 3.57% |
5 Years | 96.13 | 174.16 | 73.01 | 126.42 | 1,135,840 | 44.54 | 46.33% |
Quest Diagnostics Description
Quest Diagnostics is a leading independent provider of diagnostic testing, information, and services in the U.S. The company generates over 95% of its revenue through clinical testing, anatomic pathology, esoteric testing, and substance abuse testing with specimens collected at its national network of roughly 2,300 patient service centers, as well as multiple doctors offices and hospitals. The firm also runs a much smaller diagnostic solutions segment that provides clinical trials testing, risk assessment services, and information technology solutions. |